Make Your Share Investment Stronger With NASDAQ AEMD

By Hope Huntley 4 years ago

In the stock trading market, market makers bid and ask in the counters to the customers and complete the trading formalities out there with the given securities of the stock exchange market. However, with e-trading customers directly enroll there and order desirable shares there and sell there and achieve the most proper prices for their shares. Nasdaq is the most popular and reliable e-trading platform serving globally. Under this stock exchange, there are stocks of numerous IT firms and many more popular firms.

About Aemd

Aethlon medical Incorporation is a medical device company that engages in creating medical devices and biodefense devices worldwide to meet the health requirements smoothly. It focuses on some clinical therapeutic devices that eliminate viruses from the infected body, hemopurifier, other diagnostics devices, clinical care devices, and all. The company has its headquarter in California, established in 1991. Aethlon Medical (NASDAQ: AEMD at https://www.webull.com/quote/nasdaq-aemd) sells its share under Nasdaq stock exchange or e-trading market.

How is the performance

Aethlon is rather a small company with its market size $12m only. The beta value is thus so close to 1 which means very close to the overall market value of this company. The company earlier became much stronger with the hike 34% in the share price market. But after the hike, the share price plummets by 98%. The total of $523k revenue was accumulated by Aethlon Medical during the last twelve months. According to the data, Aemd had $475k liabilities in late 2019. To offset that liabilities Aethlon medical has very minimal cash in hand. It is said that for the past 5 years, the share price is down streaming by 55% each year. Aemd sees the total loss of 82% which is far more than the market gain of around 32%. Which is why Aethlon shareholders lost by 90%.

About cash burn

Where once the company saw an impressive up by 144%, over the last 5 years Aethlon shareholders are worrying too much. Cash burn is the amount of my that is used to raise funds and the size of the company related to its revenue. Aethlon last published its balance sheet on the march, 2020, there shows Aethlon medical has zero debt and cash of $6.9m. Whilst its in the last year balance sheet, the cash burn was approximately $5.3m. So, the cash runway of 22 months is truly concerning in nature. Because of its lower market capitalization, the cash burn identifies about 22% and this is quite significant.

Companies with such small market capital stock have usually much volatile performance. So to consider its volatility, you must analyze the future prediction, past tracks, and other data like returns, p/e ratio of NASDAQ: AEMD. The company may improve much better through debts and equity. The plus point is the company has an impressive beta value, that may be attractive to the shareholders. You can check the stock information before penny stock trading. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.